Acute coronary syndromes: Diagnosis and management, part II
Amit Kumar1, Christopher P Cannon
1Department of Hospital Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA. amkrdoc@gmail.com
Insights
ST-segment elevation myocardial infarction (STEMI) requires rapid reperfusion therapy, with primary percutaneous coronary intervention preferred. This review covers evidence-based guidelines for STEMI diagnosis and management.
Area of Science:
- Cardiology
- Emergency Medicine
Background:
- ST-segment elevation myocardial infarction (STEMI) is a severe acute coronary syndrome caused by complete coronary artery occlusion.
- Diagnosis relies on clinical presentation and electrocardiography showing ST-segment elevation.
Purpose of the Study:
- To summarize current evidence-based guidelines for STEMI diagnosis and management.
- To discuss the role of noninvasive stress testing in acute coronary syndrome assessment and revascularization decisions.
Main Methods:
- Review of current evidence-based guidelines for STEMI diagnosis and management.
- Discussion of reperfusion strategies: primary percutaneous coronary intervention and fibrinolytic therapy.
- Exploration of adjunctive therapies: antiplatelet agents and anticoagulants.
Main Results:
- Prompt reperfusion is critical for STEMI patients.
- Primary percutaneous coronary intervention is the preferred reperfusion strategy when available.
- Antiplatelet and anticoagulant therapies are essential adjuncts to reperfusion.
Conclusions:
- Timely diagnosis and implementation of reperfusion therapy are paramount in STEMI management.
- Percutaneous coronary intervention offers superior outcomes but requires timely access.
- Noninvasive stress testing aids in risk stratification and guiding revascularization decisions for acute coronary syndromes.
Abstract:
At the most severe end of the spectrum of acute coronary syndromes is ST-segment elevation myocardial infarction (STEMI), which usually occurs when a fibrin-rich thrombus completely occludes an epicardial coronary artery. The diagnosis of STEMI is based on clinical characteristics and persistent ST-segment elevation as demonstrated by 12-lead electrocardiography. Patients with STEMI should undergo rapid assessment for reperfusion therapy, and a reperfusion strategy should be implemented promptly after the patient's contact with the health care system. Two methods are currently available for establishing timely coronary reperfusion: primary percutaneous coronary intervention and fibrinolytic therapy. Percutaneous coronary intervention is the preferred method but is not always available. Antiplatelet agents and anticoagulants are critical adjuncts to reperfusion. This article summarizes the current evidence-based guidelines for the diagnosis and management of STEMI. This summary is followed by a brief discussion of the role of noninvasive stress testing in the assessment of patients with acute coronary syndrome and their selection for coronary revascularization.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:26Acute Coronary Syndrome V: Nursing Management
01:30Acute Coronary Syndrome I: Introduction
01:26Angina IV: Management